4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-26-005172
CEO sold 36,351 shares at an average $77.93 ($2,833,013)
- CEO gave up 26,198 shares (to pay taxes)
- CEO gave 26,640 shares (gift)
- CEO gave 26,640 shares (gift)
- CEO acquired 47,207 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Zovighian Bernard J CEO | 2026-05-11 | Option exercise 10b5-1 | +47,207 | 157,491.65 | D | ||
| Zovighian Bernard J CEO | 2026-05-11 | Shares withheld for taxes 10b5-1 | −26,198 | $79.96 | $2,094,792 | 125,804.65 | D |
| Zovighian Bernard J CEO | 2026-05-12 | Gift 10b5-1 | −26,640 | 99,164.65 | D | ||
| Zovighian Bernard J CEO | 2026-05-12 | Gift 10b5-1 | +26,640 | 48,390.55 | I | ||
| Zovighian Bernard J CEO | 2026-05-12 | Sale 10b5-1 | −845 | $78.40 | $66,250 | 47,545.55 | I |
| Zovighian Bernard J CEO | 2026-05-12 | Sale 10b5-1 | −35,506 | $77.92 | $2,766,762 | 12,039.55 | I |
| Derivatives | |||||||
| Zovighian Bernard J CEO | 2026-05-11 | Option exercise · Performance Rights 10b5-1 | −47,207 | 0 | D | ||
| Open-market sales · 36,351 sh · avg $77.93 · $2,833,013 | |||||||
Loading xslF345X06/doc4.xml…